This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Liver cancer is a cancer that begins in the liver. It is a very serious and complex form of cancer, and is the seventh most common cause of cancer death worldwide. The most common type of liver cancer is hepatocellular carcinoma, which accounts for 80 to 90 percent of liver cancers. Other types of liver cancer include intrahepatic cholangiocarcinoma, hepatoblastoma, and angiosarcoma. Risk factors for liver cancer include long-term infection with hepatitis B or C, cirrhosis, alcohol abuse, and diabetes. Symptoms of liver cancer include abdominal pain and swelling, jaundice, fatigue, weight loss, and yellowing of the skin and eyes. Diagnosis of liver cancer usually involves imaging tests such as ultrasound, computerized tomography (CT) scans, and magnetic resonance imaging (MRI). Blood tests, biopsies, and other tests may also be used to diagnose liver cancer. Treatment for liver cancer depends on the stage of the cancer, the size of the tumor, and the patient's overall health. Common treatments include surgery, chemotherapy, and radiation therapy. Immunotherapy and targeted therapies may also be used.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States